Memic Innovative Surgery Raises $96 Million

Memic Innovative Surgery Raises $96 Million
USA - English
Financing led by Peregrine Ventures and Ceros with participation from OurCrowd and Accelmed
Funding primarily supports commercialization of Hominis® surgical robot in the United States following FDA De Novo marketing authorization
News provided by
Share this article
Share this article
TEL AVIV, Israel and FORT LAUDERDALE, Fla., April 12, 2021 /PRNewswire/ -- Memic Innovative Surgery (Memic), a medical device company dedicated to transforming robot-assisted surgery with its proprietary technology, today announced the closing of a $96 million Series D financing. The financing round was led by Peregrine Ventures and Ceros with participation from OurCrowd and Accelmed. Funding will support commercialization of the Hominis® robotic-assisted surgical platform in the U.S. and potentially in other countries around the world as the company also plans to expand marketing and sales efforts outside the U.S. The financing will also support continued research and development efforts including expanding the company's portfolio of products and manufacturing scaleup, as well as provide world-class customer support and training.

Related Keywords

Israel , Tel Aviv , Eyal Lifschitz , Mark Goldwasser , Lynn Granito , Mauricer Ferr , Dvir Cohen , Berry Company Public Relations , Mako Surgical Inc , Drug Administration , Memic Innovative Surgery , Peregrine Ventures , Fort Lauderdale , Mako Surgical , Amemic , இஸ்ரேல் , தொலைபேசி அவிவ் , குறி கோல்ட்வாசர் , லின் கிரானிடோ , பெர்ரி நிறுவனம் பொது உறவுகள் , மாக்கோ அறுவை சிகிச்சை இன்க் , நினைவு புதுமையானது அறுவை சிகிச்சை , பெரிக்‌ரிந் முயற்சிகள் , கோட்டை லாடர்டேல் , மாக்கோ அறுவை சிகிச்சை ,